Relmada Therapeutics said an interim analysis of a study assessing a treatment for major depressive disorder is futile and unlikely to meet the primary efficacy endpoint with statistical significance.

We think that refining knowledge on these mechanisms will eventually lead to more precise and personalized strategies for ...

Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

is a safe and effective treatment for both manic and depressive symptoms. ECT is often used to treat severe forms of depression or mania in bipolar I disorder when medicines may not be effective ...

The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...

(NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”, and together with Neuronetics, the “Combined Company”) today announced that they have successfully completed the ...

b For adolescents with major depressive disorder or if OCD, posttraumatic stress disorder, or generalized anxiety disorder is present. c First-line treatment if drug interactions with fluoxetine ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

It’s estimated that 40 million adults ages 18 years and older, or 18% of the country’s adult population, experience some kind of anxiety disorder ... your anxiety treatment plan may be ...

Sexual abuse and harassment by coaches and others who held positions of power over women on the U.S. Biathlon team were ...

altered appetite and sleep/wake balance. Its severe form, major depression is classified as a mood disorder.

Dr. Christopher Kahler always wanted a career exploring "how people make meaning out of their lives." He planned to teach ...